FDA Import Refusal 799-6527987-9/11/1 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA refused shipment 799-6527987-9/11/1 from Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) on Jan 10, 2022. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 10, 2022
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY26 METFORMIN (ANTI-DIABETIC)
- Charges
- 75